Growth Flags
show if company had growth for consecutive years
| Older periods | Dec '21 | Mar '22 | Jun '22 | Sep '22 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
2.10 | 1.93 | 1.85 | 1.29 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(7.57) | (4.77) | (7.38) | (4.24) | |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
5.30 | 5.46 | 5.81 | 4.28 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(4.02) | (4.11) | (4.50) | (3.24) | |
EV/FCF |
(3.86) | (3.94) | (4.31) | (3.09) | |
Quick Ratio |
1.36 | 1.23 | 0.93 | 0.10 | |
Current Ratio |
1.58 | 1.52 | 1.17 | 0.14 | |
Net Debt/EBITDA |
(9.47) | (10.70) | (9.77) | (9.50) | |
Debt/Assets |
130.84% | 140.53% | 165.58% | 131.24% | |
Debt/Equity |
(2.22) | (2.09) | (1.77) | (1.09) | |
Asset Turnover |
0.28 | 0.29 | 0.29 | 0.31 | |
Operating CF/Net income |
0.64 | 0.97 | 0.49 | 0.73 | |
Capex/Depreciation |
(0.03) | (0.02) | (0.02) | (0.04) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
116.26% | 123.37% | 113.32% | 100.40% | |
Selling, General and Administrative Expense of Revenue |
92.71% | 85.30% | 101.39% | 99.08% | |
Intangible Assets out of Total Assets |
0.26 | 0.27 | 0.31 | 0.34 | |
Share Based Compensation of Revenue |
19.60% | 19.37% | 16.81% | 15.95% | |
Graham Net Nets |
(1.77) | (2.04) | (2.38) | (3.85) | |
Graham Number |
11.20 | 10.21 | 10.72 | 10.91 | |
Earnings Yield |
(85.24%) | (104.46%) | (111.11%) | (153.78%) | |
Free Cash Flow Yield |
(65.28%) | (71.97%) | (73.01%) | (106.82%) | |
Revenue per Share |
0.31 | 0.25 | 0.22 | 0.21 | |
Operating CF per Share |
(0.36) | (0.42) | (0.24) | (0.28) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.36) | (0.42) | (0.24) | (0.28) | |
Cash per Share |
1.24 | 0.88 | 0.66 | 0.40 | |
Shareholders Equity per Share |
(2.41) | (2.19) | (2.55) | (2.89) | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
(2.41) | (2.19) | (2.55) | (2.89) | |
Free Cash Flow |
(41.41) | (58.56) | (35.17) | (40.70) | |
Working Capital |
72.87 | 63.70 | 21.01 | (645.66) | |
Capital Expenditures |
(0.07) | (0.06) | (0.05) | (0.09) | |
Net Current Asset Value |
(553.59) | (569.30) | (618.27) | (662.45) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
(179.02%) | (175.69%) | (221.92%) | (182.68%) | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
26.69 | 24.51 | 21.37 | 22.62 | |
Average Payables |
27.00 | 21.42 | 23.35 | 20.97 | |
Average Inventory |
22.20 | 18.34 | 19.11 | 14.35 | |
Average Assets |
539.19 | 500.18 | 482.54 | 427.39 | |
Average Common Equity |
(218.79) | (262.17) | (287.34) | (321.67) |
Columns are period end dates